Close

C44H83NO9

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

A glycophytoceramide having an α-D-glucopyranosyl residue at the O-1 position and an icosa-11,14-dienoyl group attached to the nitrogen.
  • TCR Vector Products

  • TCR Cell Products

  • TCR Viral Particles

Loading...
  • TCR Clone:
  • Host Species:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Host Species Epitope Allele Vector Type Inquiry & Datasheet
TCR-YC0212 Human anti-C44H83NO9 T cell receptor (Vα10Vβ8.1), pCDTCR1 Vα10Vβ8.1 Human 1-O-(alpha-D-glucopyranosyl)-N-icosa-11,14-dienoylphytosphingosine human CD1d Lentiviral vector   Add to Cart   Datasheet
TCR-YC0213 Mouse anti-C44H83NO9 T cell receptor ((Vα14Jα18)-1), pCDTCR1 Vα14Jα18 Mouse 1-O-(alpha-D-galactopyranosyl)-N-icosa-11,14-dienoylphytosphingosine mouse CD1d Lentiviral vector   Add to Cart   Datasheet
TCR-YC0214 Mouse anti-C44H83NO9 T cell receptor ((Vα14Jα18)-2), pCDTCR1 Vα14Jα18 Mouse 1-O-(alpha-D-glucopyranosyl)-N-icosa-11,14-dienoylphytosphingosine mouse CD1d Lentiviral vector   Add to Cart   Datasheet
TCR-YC0215 Human anti-C44H83NO9 T cell receptor (Vα24Jα18), pCDTCR1 Vα24Jα18 Human 1-O-(alpha-D-glucopyranosyl)-N-icosa-11,14-dienoylphytosphingosine Human CD1d Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.